renazorb
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01560884)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- PhosphateBINDING AGENT
Phosphate binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- renazorb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01560884 | Phase 1 | Apr 1, 2012 | Parexel, Spectrum Pharmaceuticals |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Parexel | For profit | 1 | 0 | 1 | 2012 |
| Spectrum Pharmaceuticals | For profit | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1